Technology Insight: Treatment of renal failure in the intensive care unit with extended dialysis

Nature Clinical Practice Nephrology

Volumn 2, Issue 1, 2006, Pages 32-39

  Fliser, Danilo ^a   Kielstein, Jan T ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Acute renal failure; Continuous renal replacement therapy; Intensive care unit; Night time dialysis; Sustained low efficiency dialysis

Indexed keywords

UREMIC TOXIN;

ACUTE KIDNEY FAILURE; ARTIFICIAL VENTILATION; CONTINUOUS HEMOFILTRATION; CONTINUOUS RENAL REPLACEMENT THERAPY; COST; COST CONTROL; DEVICE; HEALTH CARE SYSTEM; HEMODIALYSIS; HEMOFILTRATION; HUMAN; INTENSIVE CARE UNIT; NURSING; PATIENT MONITORING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RENAL REPLACEMENT THERAPY; REVIEW;

CRITICAL ILLNESS; HUMANS; INTENSIVE CARE UNITS; KIDNEY FAILURE, ACUTE; RENAL DIALYSIS; RENAL REPLACEMENT THERAPY; TREATMENT OUTCOME;

EID: 33644819144     PISSN: 17458323     EISSN: 17458331     Source Type: Journal    
DOI: 10.1038/ncpneph0060     Document Type: Review

References (51)

1. Himmelfarb J and Ikizler TA (2000) Quantitating urea removal in patients with acute renal failure: lost art or forgotten science? Semin Dial 13: 147-149
2. Uchino S et al. (2005) Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 294: 813-818
3. Augustine JJ et al. (2004) A randomized controlled trial comparing intermittent with continuous dialysis in patients with ARF. Am J Kidney Dis 44: 1000-1007
4. Lameire N et al. (2005) Acute renal failure. Lancet 365: 417-430
5. Metnitz PG et al. (2002) Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit Care Med 30: 2051-2058
6. Kellum JA et al. (2002) The first international consensus conference on continuous renal replacement therapy. Kidney Int 62: 1855-1863
7. Uehlinger DE et al. (2005) Comparison of continuous and intermittent renal replacement therapy for acute renal failure. Nephrol Dial Transplant 20: 1630-1637
8. Venkataraman R et al. (2002) Dosing patterns for continuous renal replacement therapy at a large academic medical center in the United States. J Crit Care 17: 246-250
9. Manns B et al. (2003) Cost of acute renal failure requiring dialysis in the intensive care unit: clinical and resource implications of renal recovery. Crit Care Med 31: 449-455
10. Cole L et al. (2001) High-volume haemofiltration in human septic shock. Intensive Care Med 27: 978-986
11. Schrier RW et al. (2004) Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J Clin Invest 114: 5-14
12. Ronco C et al. (2000) Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 356: 26-30
13. Schiffl H et al. (2002) Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 346: 305-310
14. Kudoh Y et al. (1988) Slow continuous hemodialysis - new therapy for acute renal failure in critically ill patients - Part 2. Animal experiments and clinical implication. Jpn Circ J 52: 1183-1190
15. Kudoh Y and Iimura O (1988) Slow continuous hemodialysis - new therapy for acute renal failure in critically ill patients - Part 1. Theoretical consideration and new technique. Jpn Circ J 52: 1171-1182
16. Tam PY et al. (1988) Slow continuous hemodialysis for the management of complicated acute renal failure in an intensive care unit. Clin Nephrol 30: 79-85
17. Schlaeper C et al. (1999) High clearance continuous renal replacement therapy with a modified dialysis machine. Kidney Int Suppl 72: S20-S23
18. Kumar VA et al. Extended daily dialysis: a new approach to renal replacement for acute renal failure in the intensive care unit. Am J Kidney Dis 36: 294-300
19. Lonnemann G et al. (2000) Extended daily veno-venous high-flux haemodialysis in patients with acute renal failure and multiple organ dysfunction syndrome using a single path batch dialysis system. Nephrol Dial Transplant 15: 1189-1193
20. Marshall MR et al. (2001) Sustained low-efficiency dialysis for critically ill patients requiring renal replacement therapy. Kidney Int 60: 777-785
21. Kielstein JT et al. (2004) Efficacy and cardiovascular tolerability of extended dialysis in critically ill patients: a randomized controlled study. Am J Kidney Dis 43: 342-349
22. Marshall MR et al. (2002) Urea kinetics during sustained low-efficiency dialysis in critically ill patients requiring renal replacement therapy. Am J Kidney Dis 39: 556-570
23. Kumar VA et al. (2004) Extended daily dialysis vs continuous hemodialysis for ICU patients with acute renal failure: a two-year single center report. Int J Artif Organs 27: 371-379
24. Fiaccadori E et al. (2004) Removal of linezolid by conventional intermittent hemodialysis, sustained low-efficiency dialysis, or continuous venovenous hemofiltration in patients with acute renal failure. Crit Care Med 32: 2437-2442
25. Ratanarat R et al. (2005) Phosphate kinetics during different dialysis modalities. Blood Purif 23: 83-90
26. Dhondt AW et al. (2003) Studies on dialysate mixing in the Genius® single-pass batch system for hemodialysis therapy. Kidney Int 63: 1540-1547
27. Fliser D and Kielstein JT (2004) A single-pass batch dialysis system: an ideal dialysis method for the patient in intensive care with acute renal failure. Curr Opin Crit Care 10: 483-488
28. Barenbrock M et al. (2000) Effects of bicarbonate- and lactate-buffered replacement fluids on cardiovascular outcome in CVVH patients. Kidney Int 58: 1751-1757
29. Liao Z et al. (2003) Kinetic comparison of different acute dialysis therapies. Artif Organs 27: 802-807
30. Marshall MR et al. (2004) Sustained low-efficiency daily diafiltration (SLEDD-f) for critically ill patients requiring renal replacement therapy: towards an adequate therapy. Nephrol Dial Transplant 19: 877-884
31. Finkel KW and Foringer JR (2005) Safety of regional citrate anticoagulation for continuous sustained low efficiency dialysis (C-SLED) in critically ill patients. Ren Fail 27: 541-545
32. Marshall MR et al. (2003) Regional citrate anticoagulation during simulated treatments of sustained low efficiency diafiltration. Nephrology 8: 302-310
33. Morgera S et al. (2004) A simple, safe and effective citrate anticoagulation protocol for the genius dialysis system in acute renal failure. Nephron Clin Pract 98: c35-c40
34. Kielstein JT et al. (2002) High-flux hemodialysis - an effective alternative to hemoperfusion in the treatment of carbamazepine intoxication. Clin Nephrol 57: 484-486
35. Kielstein JT et al. (2003) Efficiency of high-flux hemodialysis in the treatment of valproic acid intoxication. J Toxicol Clin Toxicol 41: 873-876
36. Kielstein JT et al. (2004) One for all - a multi-use dialysis system for effective treatment of severe thallium intoxication. Kidney Blood Press Res 27: 197-199
37. Lund B et al. (2005) Efficacy of sustained low-efficiency dialysis in the treatment of salicylate toxicity. Nephrol Dial Transplant 20: 1483-1484
38. Hicks LK and McFarlane PA (2001) Valproic acid overdose and haemodialysis. Nephrol Dial Transplant 16: 1483-1486
39. Zazzo JF et al. (1995) High incidence of hypophosphatemia in surgical intensive care patients: efficacy of phosphorus therapy on myocardial function. Intensive Care Med 21: 826-831
40. Mueller BA et al. (2003) Higher renal replacement therapy dose delivery influences on drug therapy. Artif Organs 27: 808-814
41. Ahern JW et al. (2004) Experience with vancomycin in patients receiving slow low-efficiency dialysis. Hospital Pharmacy 39: 138-143
42. Fish DN and Chow AT (1997) The clinical pharmacokinetics of levofloxacin. Clin Pharmacokinet 32: 101-119
43. Kielstein JT et al. (2005) Pharmacokinetics and total elimination of meropenem and vancomycin in intensive care unit patients undergoing extended daily dialysis. Crit Care Med 33 (online ahead of print) [doi:10.1097/01.ccm. 0000190243.88133.3f]
44. van der Sande FM et al. (2001) Thermal effects and blood pressure response during postdilution hemodiafiltration and hemodialysis: the effect of amount of replacement fluid and dialysate temperature. J Am Soc Nephrol 12: 1916-1920
45. Kanagasundaram NS et al. (2003) A preliminary survey of bacterial contamination of the dialysate circuit in continuous veno-venous hemodialysis. Clin Nephrol 59: 47-55
46. Kielstein JT et al. (2004) Low dialysance of asymmetric dimethylarginine (ADMA) - in vivo and in vitro evidence of significant protein binding. Clin Nephrol 62: 295-300
47. Kielstein JT et al. (2005) Dialysate concentration and pharmacokinetics of 2F-Ara-A in a patient with acute renal failure. Eur J Haematol 74: 533-534
48. Liefeldt L et al. (2004) Treatment of secondary pulmonary hypertension with bosentan and its pharmacokinetic monitoring in ESRD. Am J Kidney Dis 43: 923-926
49. Alam M et al. (2000) Cost comparison between sustained low efficiency hemodialysis (SLED) and continuous venovenous hemofiltration (CVVH) for ICU patients with ARF. Am J Kidney Dis 35: A9
50. Ma T et al. (2002) Cost comparison between sustained low efficiency daily dialysis/diafiltration (SLEDD) and continuous renal replacement therapy for ICU patients with ARF. Nephrology 7: A54
51. Naka T et al. (2004) Prolonged daily intermittent renal replacement therapy in ICU patients by ICU nurses and ICU physicians. Int J Artif Organs 27: 380-387